Menopause Triggers Fatty Liver: Reverse It Now!

Women entering menopause face a significantly increased risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD), commonly known as fatty liver. Studies indicate a two-and-a-half times higher likelihood after menopause due to two primary factors: a decline in estrogen and reduced insulin sensitivity.

Estrogen normally helps prevent fat accumulation in the liver. As levels drop, fat can migrate to the abdomen and become inflammatory, increasing MASLD risk. Concurrently, decreased insulin efficiency leads to more circulating fatty acids, which the liver then stores, creating a vicious cycle.

Early menopause further elevates this risk, with severe liver fibrosis linked to menopause before age 40. While often silent, MASLD can lead to serious liver damage, including cirrhosis and failure. The encouraging news is that early-stage fatty liver is often reversible.

Reversing fatty liver involves adopting a nutrient-rich, low-carb, plant-forward diet emphasizing healthy fats and vegetables. Building muscle through resistance training is also crucial, as muscle aids in blood sugar management and metabolism. While research on hormone replacement therapy's role is ongoing, transdermal estrogen shows potential benefits for liver health in some studies.